Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism together with GIP and GLP-1 receptor agonism features a distinct pharmacological profile. Though Semaglutide can be a GLP-one receptor agonist and Tirzepatide combines GLP-one and GIP receptor agonism, retatrutide's triple mechanism could perhaps offer broader metabolic Added benefits. https://corepepptides.com/product/retatrutide-injection-pen/